BIOS Memory SPV I, LP
Director10% Owner

BIOS Memory SPV I, LP insider trades: Cognition Therapeutics (CGTX) stock buys and sales

Director, Cognition Therapeutics Last trade Nov 28, 2022 9 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2021
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where BIOS Memory SPV I, LP reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 28, 2022CGTX↑ Buy$32K
Nov 28, 2022CGTX↑ Buy$5K
Nov 28, 2022CGTX↑ Buy$5K
Nov 16, 2022CGTX↑ Buy$76K
Nov 16, 2022CGTX↑ Buy$12K
Nov 16, 2022CGTX↑ Buy$12K
Nov 15, 2022CGTX↑ Buy$1.4M
Nov 15, 2022CGTX↑ Buy$221K
Nov 15, 2022CGTX↑ Buy$210K
Oct 13, 2021CGTX↑ Buy$1.7M
Oct 13, 2021CGTX↑ Buy$280K
Oct 13, 2021CGTX↑ Buy$266K
Oct 13, 2021CGTX↓ Sell$1K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About BIOS Memory SPV I, LP's insider trades

BIOS Memory SPV I, LP is a director at Cognition Therapeutics (CGTX). Since Oct 13, 2021, it has reported 12 open-market purchases worth $4.2M and 1 sale worth $1K on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include grants and awards (5 filings), conversions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CGTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.